What Is Clinical Evidence in Speech-Language Pathology? A Scoping Review.
Journal
American journal of speech-language pathology
ISSN: 1558-9110
Titre abrégé: Am J Speech Lang Pathol
Pays: United States
ID NLM: 9114726
Informations de publication
Date de publication:
16 11 2022
16 11 2022
Historique:
pubmed:
9
11
2022
medline:
19
11
2022
entrez:
8
11
2022
Statut:
ppublish
Résumé
Two disparate models drive American speech-language pathologists' views of evidence-based practice (EBP): the American Speech-Language-Hearing Association's (2004a, 2004b) and Dollaghan's (2007). These models discuss evidence derived from clinical practice but differ in the terms used, the definitions, and discussions of its role. These concepts, which we unify as We conducted a scoping review to identify terms ascribed to clinical evidence and their descriptions. We searched the peer-reviewed, accessible, speech-language pathology intervention literature from 2005 to 2020. We extracted the terms and descriptions, from which three types of clinical evidence arose. We then used an open-coding framework to categorize positive and negative descriptions of clinical expertise and summarize the role of clinical evidence in decision making. Seventy-eight articles included a description of clinical evidence. Across publications, a single term was used to describe disparate concepts, and the same concept was given different terms, yet the concepts that authors described clustered into three categories: These results outline a shared language for SLPs to discuss their clinical evidence with researchers, families, allied professionals, and each other. Clarification of the terminology, associated definitions, and the contributions of clinical evidence to good clinical decision-making informs EBP models in speech-language pathology. https://doi.org/10.23641/asha.21498546.
Identifiants
pubmed: 36346976
doi: 10.1044/2022_AJSLP-22-00203
doi:
Types de publication
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM